Our results showed that HBV could suppressed NFAT5 expression by inducing hypermethylation of the AP1-binding site in the NFAT5 promoter and inhibiting miR-30e-5p/MAP4K4/DARS2 pathway in hepatoma cells. This evidence concerns the gene DARS2 and hepatocellular carcinoma.